YY2201 is a potent, selective inhibitor of ATR with an IC50 of 8 nM. It exhibits over 200 times greater selectivity for ATR compared to mTOR. Additionally, YY2201 is capable of inhibiting tumor progression across a wide range of cancer types.
Target-Kategorie:
ATM/ATR
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
